T. Stephen Thompson
Directeur/Membre du Conseil chez SC Launch!, Inc.
Profil
T.
Stephen Thompson is currently the Director at SC Launch!, Inc. He was previously the Director at Matritech, Inc. from 1994 to 2007 and the Director at MZT Holdings, Inc. from 1994 to 2012.
He also served as the President of Immtech Pharmaceuticals, Inc. Mr. Thompson holds an MBA from Harvard University and an undergraduate degree from the University of Cincinnati (Ohio).
Postes actifs de T. Stephen Thompson
| Sociétés | Poste | Début |
|---|---|---|
SC Launch!, Inc.
 SC Launch!, Inc. Miscellaneous Commercial ServicesCommercial Services SC Launch!, Inc. operates as a not-for-profit organization. It supports growth of firms in the advanced manufacturing and materials, life sciences, and information technology industries. The company was founded on April 13, 2006 and is headquartered in Columbia, SC. | Directeur/Membre du Conseil | - |
Anciens postes connus de T. Stephen Thompson
| Sociétés | Poste | Fin |
|---|---|---|
MZT Holdings, Inc.
 MZT Holdings, Inc. Medical SpecialtiesHealth Technology MZT Holdings, Inc. principal activity is to develop, manufacture, market, distribute and licensing of cancer diagnostic technologies and products. The products are based on proprietary nuclear matrix protein technology. The company has developed minimally invasive cancer diagnostic tests for bladder and colon cancer, cervical cancer, breast cancer and prostrate cancer, using proprietary technology and expertise. It was founded in 1987 and is headquartered Foxborough, MA. | Directeur/Membre du Conseil | 20/06/2012 |
Matritech, Inc.
 Matritech, Inc. Medical SpecialtiesHealth Technology Matritech, Inc. is a biotechnology company principally engaged in the development, manufacture, marketing, distribution and licensing of cancer diagnostic technologies, products and services | Directeur/Membre du Conseil | 13/12/2007 |
Immtech Pharmaceuticals, Inc.
 Immtech Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immtech Pharmaceuticals, Inc. develops and distributes pharmaceuticals. The company's efforts reflect extensive work in clinical research, new product development and marketing. The company focuses on developing a new treatment for the Hepatitis C virus. Immtech Pharmaceuticals was founded on October 15, 1984 and is headquartered in New York, NY. | President | 01/05/2006 |
Formation de T. Stephen Thompson
| Harvard University | Masters Business Admin |
| University of Cincinnati (Ohio) | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Matritech, Inc.
Matritech, Inc. Medical SpecialtiesHealth Technology Matritech, Inc. is a biotechnology company principally engaged in the development, manufacture, marketing, distribution and licensing of cancer diagnostic technologies, products and services | Health Technology |
Immtech Pharmaceuticals, Inc.
Immtech Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immtech Pharmaceuticals, Inc. develops and distributes pharmaceuticals. The company's efforts reflect extensive work in clinical research, new product development and marketing. The company focuses on developing a new treatment for the Hepatitis C virus. Immtech Pharmaceuticals was founded on October 15, 1984 and is headquartered in New York, NY. | Health Technology |
SC Launch!, Inc.
SC Launch!, Inc. Miscellaneous Commercial ServicesCommercial Services SC Launch!, Inc. operates as a not-for-profit organization. It supports growth of firms in the advanced manufacturing and materials, life sciences, and information technology industries. The company was founded on April 13, 2006 and is headquartered in Columbia, SC. | Commercial Services |
MZT Holdings, Inc.
MZT Holdings, Inc. Medical SpecialtiesHealth Technology MZT Holdings, Inc. principal activity is to develop, manufacture, market, distribute and licensing of cancer diagnostic technologies and products. The products are based on proprietary nuclear matrix protein technology. The company has developed minimally invasive cancer diagnostic tests for bladder and colon cancer, cervical cancer, breast cancer and prostrate cancer, using proprietary technology and expertise. It was founded in 1987 and is headquartered Foxborough, MA. | Health Technology |
